Speech-Language Pathologists in Williamson, NY Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Christine R. De Fisher, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5598 Pease Rd, Williamson, NY 14589 Phone: 315-589-2543 Fax: 315-589-2539 |
Kristen Jacobs, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 4309 Lake Road, Williamson, NY 14589 Phone: 585-727-3220 |
Mrs. Mary Margaret Elwell, C.C.C./LSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4440 Ridge Rd, Williamson, NY 14589 Phone: 315-589-2400 Fax: 315-589-2670 |
Mrs. Andrea Michelle Franke, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5416 Ridge Rd, Williamson, NY 14589 Phone: 585-749-9578 |
News Archive
Video games do not adequately meet older adults' needs
Advances in technology have brought the video gaming experience closer to that of traditional physical games. Although systems, such as the Wii, that incorporate these features fly off the shelves, the increasingly complex technology may alienate certain segments of the population, including seniors.
Simple tool can help doctors estimate survival for patients with long bone metastases
A simple three-factor tool can help doctors estimate survival time in patients with long bone metastases (LBMs)- advanced cancer that has spread to the bones of the limbs, reports a study in the February 7, 2018, issue of The Journal of Bone & Joint Surgery.
New mass spectrometry helps identify bacteria in clinical specimens within minutes
New mass spectrometry technology is helping Le Bonheur Children's physicians analyze microbiology samples quickly - identifying specific bacteria present in a sample within minutes.
EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
› Verified 1 days ago
Occupational Therapists
Chiropractors
Speech-Language Pathologists
Physical Therapists
Podiatrists